Pelvic Reconstruction Market is expected to enjoy a valuation of US$ 277.8 Million by the end of 2022

[250 Pages Report] As per Future Market Insights, the global pelvic reconstruction market was around US$ 270.5 Mn in 2021 and is projected to exhibit at CAGR of 2.8% over the forecast period (2022-2032), surpassing US$ 366.9 Mn in 2032.Growth is due to the increased use of vaginal mesh, slings, and pessaries in the healthcare sector owing to rising cases of pelvic floor disorders.

Furthermore, increasing awareness regarding vaginal health due to growing cases of pelvic disorders and deformities have surged the need for pelvic reconstruction products. On the back of this, key players are vying to develop systems that can be approved by regulatory authorities such as the FDA.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15500

Additionally, growing acceptance of pelvic floor reconstruction procedures in hospitals and specialty clinics is prompting the adoption of advanced systems for accurate and speedy recovery. There is also an increase in the research and development on ways to handle pelvic floor disorders by mitigating the risk factors.

Increasing use of tissue engineering to support pelvic floor and also promotes tissue repair. This is also highly biocompatible compared to the general approach of using polypropylene mesh. Hence, several ongoing research is focusing on tissue engineering such as the use of fibroblasts and stem cells is supporting the growth in pelvic reconstruction market.

Key Takeaways from Market Study

Based on product type, vaginal sling systems held approximately 2% market value share in 2021, owing to rising cases of pelvic floor disorders.
Surgical procedure is set to lead the market, in terms of procedures, and contributed around 9% of revenue in 2021.
By indication, pelvic organ prolapse is expected to register growth at a CAGR of 7% during the forecast period.
By pelvic organs, the vagina is the most affected organ and the segment held a share of about 6% in 2021.
North America is considered as the leading region with a value share of 9% in 2021, owing to the high prevalence of pelvic floor disorders in the region.

"Rising initiatives to promote safety and mitigate risk, as well as the increasing research and development for the improvement of treatment approaches is set to propel the sales of pelvic reconstruction products across the globe," says an analyst of Future Market Insights.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15500

Market Competition

The market for pelvic reconstruction consists of a number of local as well as established players within the market sphere. There is increased research and development to meet the current needs of the population.

In 2019, as per research conducted by Royal Hallamshire Hospital, UK, Ulrich et al. demonstrated that endometrial MSCs seeded onto gelatin-coated polyamide mesh had an anti-inflammatory effect and promoted neovascularization in a rat model.
Onkos Surgical declared in July 2022 that its My3D® Personalized Pelvic Reconstruction system had been granted 510(k) approval.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the pelvic reconstruction market in its latest study, presenting a historical demand assessment of 2012 - 2021 and projections for 2022 - 2032. The global pelvic reconstruction market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on the product - (vaginal mesh(biological mesh, synthetic mesh), vaginal sling systems, and vaginal pessary), by procedure (non-surgical and surgical (obliterative surgery and reconstructive surgery (native tissue repair, colporrhaphy, sacrocolpopexy, sacrohysteropexy, transvaginal graft, and sling surgery), by indication (pelvic organ prolapse (vaginal prolapse and rectal prolapse), urinary incontinence, interstitial cystitis, and fistulae), by pelvic organs (uterus, ovaries, vagina, and fallopian tubes), by end user (hospitals, ambulatory surgical centers, and specialty clinics), across seven key regions of the world.

Enquiry/Query @ https://www.futuremarketinsights.com/ask-question/rep-gb-15500

Key Players :

Johnson & Johnson Services, Inc.
Coloplast A/S
Dipromed Srl
Boston Scientific Corporation (American Medical Systems Inc.)
pfm medical ag
Betatech Medical
Promedon Group
Caldera Medical
Cook Medical
MEDGYN PRODUCTS, INC.
CooperSurgical, Inc.
DIMA S.L.
Digitimer Ltd
Bray Group Ltd,
medesign Ingenieur-Consulting GmbH
Panpac Medical Corp.
Bioteque America Inc.
Mediplus Ltd.
neomedic international
Dyna Mesh
CL Medical
A.M.I. GmbH
Meta Biomed Co., Ltd.
Onkos Surgical

Key Market Segments Covered In Pelvic Reconstruction Industry Research

By Product:

Vaginal Mesh
Biological Mesh
Synthetic Mesh
Vaginal Sling Systems
Vaginal Pessary

By Procedure:

Non-Surgical
Surgical
Obliterative surgery
Reconstructive surgery
Native Tissue Repair (uterosacral ligament suspension and sacrospinous fixation)
Colporrhalphy
Sacrocolpopexy
Sacrohysteropexy
Transvaginal graft
Sling Surgery

By Indication:

Pelvic Organ Prolapse
Vaginal Prolapse
Rectal Prolapse
Urinary Incontinence
Interstitial Cystitis
Fistulae

By Pelvic Organs:

Uterus
Ovaries
Vagina
Fallopian Tubes

By End User:

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

This release was published on openPR.